Quick10K

⚲

Helen of Troy

Filings

10-K	2021-02-28	Filed 2021-04-29
10-Q	2020-11-30	Filed 2021-01-08
10-Q	2020-08-31	Filed 2020-10-09
10-Q	2020-05-31	Filed 2020-07-10
10-K	2020-02-29	Filed 2020-04-29
10-Q	2019-11-30	Filed 2020-01-09
10-Q	2019-08-31	Filed 2019-10-10
10-Q	2019-05-31	Filed 2019-07-10
10-K	2019-02-28	Filed 2019-04-29
10-Q	2018-11-30	Filed 2019-01-09
10-Q	2018-08-31	Filed 2018-10-10
10-Q	2018-05-31	Filed 2018-07-10
10-K	2018-02-28	Filed 2018-04-30
10-Q	2017-11-30	Filed 2018-01-09
10-Q	2017-08-31	Filed 2017-10-10
10-Q	2017-05-31	Filed 2017-07-10
10-K	2017-02-28	Filed 2017-05-01
10-Q	2016-11-30	Filed 2017-01-09
10-Q	2016-08-31	Filed 2016-10-11
10-Q	2016-05-31	Filed 2016-07-11
10-K	2016-02-29	Filed 2016-04-29
10-Q	2015-11-30	Filed 2016-01-11
10-Q	2015-08-31	Filed 2015-10-13
10-Q	2015-05-31	Filed 2015-07-10
10-K	2015-02-28	Filed 2015-04-29
10-Q	2014-11-30	Filed 2015-01-09
10-Q	2014-08-31	Filed 2014-10-10
10-Q	2014-05-31	Filed 2014-07-10
10-K	2014-02-28	Filed 2014-04-29
10-Q	2013-11-30	Filed 2014-01-09
10-Q	2013-08-31	Filed 2013-10-10
10-K	2013-02-28	Filed 2013-04-29
10-Q	2012-11-30	Filed 2013-01-09
10-Q	2012-08-31	Filed 2012-10-10
10-Q	2012-05-31	Filed 2012-07-10
10-K	2012-02-29	Filed 2012-04-30
10-Q	2011-11-30	Filed 2012-01-06
10-Q	2011-08-31	Filed 2011-10-07
10-Q	2011-05-31	Filed 2011-07-11
10-K	2011-02-28	Filed 2011-05-16
10-Q	2010-11-30	Filed 2011-01-10
10-Q	2010-08-31	Filed 2010-10-06
10-Q	2010-05-31	Filed 2010-07-09
10-K	2010-02-28	Filed 2010-05-13
10-Q	2009-11-30	Filed 2010-01-11

Reports

8-K	2020-10-08
8-K	2020-10-06
8-K	2020-08-26
8-K	2020-07-09
8-K	2020-05-14
8-K	2020-05-04
8-K	2020-04-28
8-K	2020-03-30
8-K	2020-03-17
8-K	2020-01-28
8-K	2020-01-23
8-K	2020-01-08
8-K	2019-12-19
8-K	2019-10-08
8-K	2019-08-23
8-K	2019-07-09
8-K	2019-06-21
8-K	2019-05-21
8-K	2019-04-26
8-K	2019-01-08
8-K	2018-11-07
8-K	2018-10-09
8-K	2018-08-22
8-K	2018-07-09
8-K	2018-04-26
8-K	2018-03-01
8-K	2018-01-24
8-K	2018-01-08

Helen of Troy Financials

HELE Metrics, Comps, Filings

Quarterly | Annual

Valuation ($BB)

Market Cap, Enterprise Value

Balance Sheet ($BB)

Assets, Equity

Income Statement ($BB Quarterly)

Revenue, G Profit, Net Income

Cash Flow ($BB Quarterly)

Ops, Inv, Fin


Comps ($MM TTM)	Market Cap	Gross Margin	EV/EBITDA	Ret on Assets	Assets	Liabilities	Revenue	G Profit	Net Income	EBITDA	EV
Aries I Acquisition Corp. (RAMMU)
024 Pharma (EEIG)
Beauty Health Co (VSPRW)
Aquarius I Acquisition Corp. (AQUI)
MIZUHO FINANCIAL GROUP INC (MZHOF)
Eucrates Biomedical Acquisition Corp. (EUCRW)
11 Good Energy (ELVN)
180 Life Sciences Corp. (ATNFW)
1347 Capital Corp (TFSC)
Avanti Acquisition Corp. (AVAN-WT)
CORDIA CORP (CORG)
FCCC INC (FCIC)
Biofrontera Inc. (BFRI)
Ameren Illinois Co (AILNP)
MITSUBISHI UFJ FINANCIAL GROUP INC (MBFJF)
Janus International Group, Inc. (JBI-WT)
23andMe Holding Co. (MEUSW)
OceanTech Acquisitions I Corp. (OTECU)
Palayan Resources, Inc. (PLYN)
ALABAMA POWER CO (APRCP)


Balance Sheet ($MM)	2011-08-31	2011-11-30	2012-02-29	2012-05-31	2012-08-31	2012-11-30	2013-02-28	2013-05-31	2013-08-31	2013-11-30	2014-02-28	2014-05-31	2014-08-31	2014-11-30	2015-02-28	2015-05-31	2015-08-31	2015-11-30	2016-02-29	2016-05-31	2016-08-31	2016-11-30	2017-02-28	2017-05-31	2017-08-31	2017-11-30	2018-02-28	2018-05-31	2018-08-31	2018-11-30	2019-02-28	2019-05-31
Cash	25	35	22	21	22	16	13	12	10	29	70	29	25	21	12	15	19	21	226	23	26	17	23	17	14	21	21	17	20	19	12	18
Accounts Receivable	201	229	195	188	208	258	220	206	231	280	213	217	217	289	222	210	227	289	218	205	223	290	230	208	238	302	273	256	314	339	280	263
Inventory	258	252	246	260	319	306	281	288	307	290	289	298	352	319	293	299	348	339	302	319	317	301	289	312	326	286	252	256	285	301	302	335
PP&E	85	87	163	168	170	169	176	189	206	205	201	202	210	210	208	209	212	218	224	230	234	238	241	246	249	251	239	243	251	254	254	257
Assets	1,283	1,301	1,436	1,433	1,509	1,534	1,474	1,461	1,518	1,559	1,533	1,488	1,741	1,764	1,654	1,687	1,747	1,782	1,870	1,842	1,856	1,889	1,813	1,775	1,798	1,775	1,621	1,603	1,695	1,725	1,650	1,703
Accounts Payable	105	97	70	73	106	86	72	87	109	93	76	85	115	101	99	113	143	123	104	111	131	135	112	136	136	109	129	126	151	146	144	139
Long-Term Debt	178	178	178	178	175	175	175	187	204	211	193	191	116	116	433	439	479	475	624	587	549	565	486	454	444	426	290	300	301	340	321	321
Liabilities	557	537	639	606	657	644	547	516	547	549	504	708	939	905	749	755	836	815	940	885	864	909	792	750	761	790	607	579	619	692	653	667
Stockholders' Equity	726	764	797	827	852	890	927	944	971	1,010	1,029	780	802	859	905	932	911	968	930	956	992	980	1,021	1,024	1,037	984	1,014	1,024	1,076	1,033	997	1,036


Income Statement ($MM)	2011-08-31	2011-11-30	2012-02-29	2012-05-31	2012-08-31	2012-11-30	2013-02-28	2013-05-31	2013-08-31	2013-11-30	2014-02-28	2014-05-31	2014-08-31	2014-11-30	2015-02-28	2015-05-31	2015-08-31	2015-11-30	2016-02-29	2016-05-31	2016-08-31	2016-11-30	2017-02-28	2017-05-31	2017-08-31	2017-11-30	2018-02-28	2018-05-31	2018-08-31	2018-11-30	2019-02-28	2019-05-31
Revenue	277	339	294	300	287	375	326	305	319	381	313	312	320	436	378	345	369	446	386	348	368	444	377	360	378	453	391	355	394	431	385	376
Cost of Revenue	165	206	171	179	170	226	194	184	196	233	187	192	186	254	213	202	221	263	224	196	205	250	211	203	211	251	230	208	238	249	227	223
Gross Profit	112	133	123	121	117	148	132	120	123	148	126	120	134	181	165	143	148	183	162	152	163	194	166	156	168	202	161	147	155	182	158	154
R&D
SG&A	82	91	87	90	86	101	92	87	93	98	109	87	109	116	116	114	116	127	143	122	125	131	120	124	130	134	48	102	104	121	112	106
Tax		1	-3	-4	5	6	5	3	5	9	3	3	2	6	5	3	5	6	4	0	5	2	1	-13	7	11	21	3	4	4	3	3
Net Income																										-30	60	38	44		37	41


Cash Flow ($MM)	2011-08-31	2011-11-30	2012-02-29	2012-05-31	2012-08-31	2012-11-30	2013-02-28	2013-05-31	2013-08-31	2013-11-30	2014-02-28	2014-05-31	2014-08-31	2014-11-30	2015-02-28	2015-05-31	2015-08-31	2015-11-30	2016-02-29	2016-05-31	2016-08-31	2016-11-30	2017-02-28	2017-05-31	2017-08-31	2017-11-30	2018-02-28	2018-05-31	2018-08-31	2018-11-30	2019-02-28	2019-05-31
Cash Operating		27	48	9	2	14	63	47	10	34	63	3	15	45	115	37	14	21	113	42	44	53	89	42		58	117	29	8		91	16
Cash Investing		15	-165	-3	-2	-1	-8	-17	-18	-4	-2	-2	-198	-1	-2	-45	-3	-6	-9	-214	-5	-5	-6	-13		-3	55	-4	-9		-4	-4
Cash Financing		-32	103	-7	2	-19	-58	-31	5	-11	-20	-42	178	-48	-122	11	-7	-13	101	-30	-36	-58	-77	-35		-47	-172	-28	3		-94	-5